Cite
MLA Citation
Talia M. Mota et al.. “No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy.” AIDS, vol. 31, 2017, p. . http://access.bl.uk/ark:/81055/vdc_100052937167.0x00002a